Findings aid antiviral drug discovery
Many viral infections, such as the common cold, cause mild illnesses that the body’s immune system eventually defeats. But when viruses cause severe disease, doctors have few options for effective treatment.
Studying mice with a variety of viral infections, scientists at Washington University School of Medicine in St. Louis have demonstrated a way to dial up the body’s innate immune defenses while simultaneously attacking a protein that many viruses rely on to replicate.
The findings, published Oct. 19 in Nature Immunology, reveal previously unknown weapons in the body’s antiviral immune arsenal and provide guidelines for designing drugs that could be effective against a broad range of viruses. The strategy involves enhancing the body’s interferon signaling system, long understood to be a vital part of antiviral defenses.
“We’ve discovered a new component of the interferon system,” said senior author Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine. “It does something that other components don’t do, and it works on both sides of the fence: It dials up the body’s internal genes that fight viruses, and it attacks viral proteins directly.”
Holtzman and lead author Yong Zhang, PhD, an instructor in pulmonary medicine, suspect that the researchers’ one-two punch against the virus may explain the large difference in survival rates between control mice and mice genetically engineered to have increased signaling in their interferon systems.
When infected with encephalomyocarditis virus, which causes severe damage to vital organs including the brain, heart and pancreas, 97 percent of the genetically engineered mice survived, compared with none of the control mice. Even when the concentration of the injected virus was increased 100-fold, 82 percent of the genetically altered mice survived. And at 100-fold lower concentrations, all genetically engineered mice survived the infection, compared with only 25-28 percent of the control mice.
Holtzman pointed out that past research by other groups has shown that increasing the amount of interferon directly results in some improvements in fighting viruses, but not to the same extent as the current work. In addition, more modest improvements shown by other investigators usually are accompanied by autoimmune problems resulting from the chronically activated immune response. Despite the strong antiviral immune response seen in the new study, Holtzman and his colleagues reported no evidence of autoimmune disease in these mice.
Read more: Study reveals new, potent way to boost immunity and fight viruses
The Latest on: Antiviral immune response
[google_news title=”” keyword=”antiviral immune response” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antiviral immune response
- One jab of measles vaccine more likely to be ineffective in children born by C-section, study findson May 14, 2024 at 1:32 pm
A single jab of the double-dose measles vaccine could be up to 2.6 times more likely to be completely ineffective in children born by C-section, compared to those born naturally, new research has ...
- COVID-19 May Damage Visionon May 14, 2024 at 1:30 pm
Researchers discovered that SARS-CoV-2 can penetrate the blood-retinal barrier, potentially causing long-term eye damage.
- Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlightson May 14, 2024 at 5:22 am
Announced positive survival data from ongoing randomized phase 2 clinical trial of CAN-2409 in borderline resectable pancreatic cancerPhase 2 ...
- New study shows certain combinations of antiviral proteins are responsible for lupus symptoms and affect treatment outcomeson May 13, 2024 at 10:27 am
Researchers say they have uncovered insights as to why lupus symptoms and severity present differently in individuals with the autoimmune condition, which affects up to 1.5 million Americans. The team ...
- New study shows certain combinations of antiviral proteins are responsible for lupus symptomson May 13, 2024 at 9:43 am
The full report, published in Cell Reports Medicine on May 13, concludes that specific combinations and elevated levels of immune system proteins ... may be to blame for these poor treatment responses ...
- Vitamin D levels associated with enhanced immune response against hepatitis B virus: Studyon May 12, 2024 at 8:15 pm
A recent study by Catharina Gerhards and colleagues looked in depth into the intricate relationship between vitamin D levels and immune response in patients with chronic hepatitis B (CHB) ...
- Genetic Variation Linked to Higher Risk of Viral Infections, Study Revealson May 10, 2024 at 6:30 pm
The research, published today in Blood, and funded by the European Research Council (ERC) and Barts Charity, suggests that new drugs which target these immune system mechanisms could improve the ...
- ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulatoron May 8, 2024 at 1:17 am
ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, ...
- Gut-Brain Treatment Goes Viralon May 6, 2024 at 9:16 am
It’s not just gut bacteria that connect our guts to our brains. Tiny viruses also have an outsized role to play.
- Key protein regulates immune response to viruses in mammal cellson April 17, 2024 at 5:00 pm
For cells to protect themselves from viral infections, a series of immune responses typically occur, including programmed cell death called apoptosis and interferon signaling. While apoptosis is a ...
via Bing News